SU11274

SU11274

Catalog Number:
L002368433APE
Mfr. No.:
APE-A2678
Price:
$333
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          SU11274 is a potent and selective inhibitor of Met kinase with IC50 value of 10nM [1].
          SU11274 shows high selectivity toward Met kinase versus a serine/threonine kinase, cyclin-dependent kinase 2 (CDK2), or other receptor tyrosine kinases, including epidermal growth factor receptor (EGFR) and platelet-derived growth factor receptor β (PDGFRβ) [1].
          SU11274 has revealed to inhibit autophosphorylation of Met at kinase tyrosines 1234/1235 in NIH3T3 cells expressing drug-sensitive or drug-resistant MET mutants and human lung cancer cell line H1993, however, concomitantly, increase total MET levels dose-dependently. Cells treated with SU11274 (2 μM for 16 h) has shown a reduction of Met Ubiquitination [2].

          [1] Wang X1, Le P, Liang C, Chan J, Kiewlich D, Miller T, Harris D, Sun L, Rice A, Vasile S, Blake RA, Howlett AR, Patel N, McMahon G, Lipson KE. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol Cancer Ther. 2003 Nov;2(11):1085-92.
          [2] Leiser D1, Pochon B1, Blank-Liss W1, Francica P1, Glück AA1, Aebersold DM1, Zimmer Y1, Medová M2. Targeting of the MET receptor tyrosine kinase by small molecule inhibitors leads to MET accumulation by impairing the receptor downregulation. FEBS Lett. 2014 Mar 3;588(5):653-8.

      • Properties
        • Alternative Name
          (3Z)-N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-(4-methylpiperazine-1-carbonyl)-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide
          CAS Number
          658084-23-2
          Molecular Formula
          C28H30CIN5O4S
          Molecular Weight
          568.09
          Appearance
          A solid
          Purity
          Purity ≥95.00%
          Solubility
          ≥28.4 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Yu-meng Miao, Ya-jing Zhang, et al. "Oral administration of curcumin ameliorates pulmonary fibrosis in mice through 15d-PGJ2-mediated induction of hepatocyte growth factor in the colon." Acta Pharmacologica Sinica (2020);21 July 2020. PMID:32694760
          2. Tong X, Liang R, et al. "Suhuang Antitussive Capsules-Ameliorative Effects on LPS-Induced Sputum Obstruction in Mice Through Promoting HGF Secretion." Front Pharmacol, 10, 1422 2019 Dec 19. PMID:31920638
          3. Guan C, Qiao S, et al. "Orally administered berberine ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting activation of PPAR-γ and subsequent expression of HGF in colons." Toxicol Appl Pharmacol. 2018 Mar 15;343:1-15. PMID:29408570
          4. Xia Y, Xia YF, et al. "Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice through promoting the generation of hepatocyte growth factor via PPAR-γ in colon." Br J Pharmacol. 2016 Apr;173(7):1219-35. PMID:26750154

    We Also Recommend

    10Panx

    $180

    10Panx

    $240

    Butein

    $231

    TGX-221

    $204

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.